Most new drugs cost too much at launch, watchdog ICER says
Two-thirds of new drugs reviewed by the watchdog group ICER launched at prices it calls too high. The median net price of a new drug rose from $190,000 in 2022 to $257,000 in 2025, after inflation. ICER also said four in 10 prescriptions for these drugs were rejected. It asked drugmakers for "fair pricing."
Where this came from. 2 outlets reported this. We read them, then wrote the sixty words above.